Murphy signs bill scheduling tianeptine as Schedule II controlled substance in New Jersey - wrnjradio.com
New Jersey has scheduled tianeptine as a Schedule II controlled substance, imposing strict regulatory controls on its handling, prescribing, and dispensing.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 17, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies operating in New Jersey that may handle tianeptine. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate, as the bill has been signed into law.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Tianeptine is now a Schedule II controlled substance in New Jersey, subject to all corresponding federal and state controlled substance regulations.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies operating in New Jersey that may handle tianeptine.
What you must do
Review current inventory and dispensing practices for tianeptine; ensure compliance with Schedule II requirements, including secure storage, record-keeping, and prescription validation.
Deadline
Immediate, as the bill has been signed into law.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Pharmacy reimbursement law goes into effect Wednesday - Alabama Daily News
- DEA Adds Second Step to Reporting Procedure for Controlled Substance Theft or Loss - reedsmith.com
- California Expands Oversight of Non-Resident Pharmacies With New PIC Licensure and Compliance Requirements - hinshawlaw.com
- DEA to publish 4th extension of telehealth prescribing rule in wave of relief for virtual care providers - fiercehealthcare.com
- DEA extends telemedicine flexibilities for controlled substance prescribing for 2026 - jdsupra.com